Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CannTrust Holdings Inc CNTTQ

CannTrust Holdings Inc is engaged in the business of producing and distributing medical cannabis in Canada. Its facility is located at Vaughan, Ontario in Canada. Its brands include LIIV, ESCAPE, SYNR.G and Peak Leaf.

GREY:CNTTQ - Post Discussion

CannTrust Holdings Inc > CNTTQ LICENSES REINSTATED FOR VAUGHN MFC FACILITY
View:
Post by Humanist on Aug 06, 2020 8:00am

CNTTQ LICENSES REINSTATED FOR VAUGHN MFC FACILITY

CannTrust Licenses Reinstated for Vaughan Manufacturing Facility
 August 6, 2020 - 7:15 AM EDT
 
 
Company Expects Products to be Available in Q4 2020
VAUGHAN, ON, Aug. 6, 2020  /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") announced today that it has received notice from Health Canada that the Company's licenses for its Vaughan Manufacturing Facility (the "Vaughan facility") have been reinstated, effective immediately.
 
Over the past 12 months, CannTrust has been working diligently to resolve regulatory deficiencies within its business. On May 29, 2020, the Company confirmed it had received notice of license reinstatement for its Fenwick Perpetual Harvest Facility and immediately recommenced cultivation operations at this location, which are proceeding as planned.

"Our license reinstatement is the result of an enormous amount of hard work by the CannTrust team," said Greg Guyatt, Chief Executive Officer at CannTrust. "Today marks the beginning of the next chapter in CannTrust's history. We have used the last 12 months to improve every aspect of our business, placing a determined focus on regulatory compliance as we remediated, restructured, and evolved. We are excited to return to work with our partners to provide our consumers and patients with high-quality cannabis products."

CannTrust will restart manufacturing operations at its Vaughan facility imminently. With all licenses now reinstated, the Company expects to have cannabis products available during the fourth quarter of 2020.
"CannTrust has undergone significant organizational and operational changes as part of our remediation activities," said Dr. Ilana Platt, the Company's Chief Regulatory Officer. "Regulatory compliance, risk management, and effective oversight are integral to everything we do."
CannTrust remains under CCAA protection to facilitate the Company's efforts to resolve its civil litigation exposures and complete its review of strategic alternatives. These efforts are ongoing, and the Company is unable to predict either their timing or their outcome.

In the meantime, the Company remains without meaningful revenues and has terminated or laid-off a significant portion of its workforce. CannTrust plans to begin operations at its Vaughan facility immediately following today's announcement as an important next step towards rebuilding stakeholder trust and delivering high-quality, innovative products to its patients and customers.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities